Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 12, 2025 • 9:00 AM ET

Date/Time Source News Release
03/21/2025 02:38 PM EDT GlobeNewswire Impact Biomedical Inc. Announcement Stock Activity/Pricing
02/26/2025 08:30 AM EST GlobeNewswire DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
02/26/2025 08:30 AM EST GlobeNewswire Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"
01/23/2025 04:30 PM EST GlobeNewswire Impact BioMedical Inc. to Present at The Microcap Conference
12/27/2024 10:00 PM EST TheNewsWire Universal Ibogaine Provides Bi-Weekly Default Status Report on Year-End Filings and Update on Belize Property Sale
12/12/2024 12:15 AM EST TheNewsWire Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property
11/26/2024 07:00 AM EST TheNewsWire Universal Ibogaine advises of Offer to purchase Belize property and update on application for Management Cease Trade Order
11/19/2024 08:00 AM EST GlobeNewswire Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
11/18/2024 08:00 PM EST TheNewsWire Universal Ibogaine Advises of Application for Management Cease Trade Order
10/15/2024 06:00 AM EDT GlobeNewswire Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker(TM) Technology Targeting Inflammatory Disease
Page